��������

David Schutzbank is a seasoned professional in regulatory affairs and legal practice, currently serving as Senior Manager of Regulatory Affairs at PAI Pharma since July 2022. Prior to this role, David held similar positions at Vertice Pharma and Jacobus Pharmaceutical Company, Inc., where responsibilities encompassed managing regulatory affairs and quality assurance. David's background also includes experience as a Clinical Research Associate at Bradstreet Clinical Research Associates and a solo practitioner in law, specializing in intellectual property at Cahill Gordon & Reindel. David's educational credentials include a J.D. in Intellectual Property from the University of Pennsylvania Carey Law School and an A.B. in Biology from Washington University in St. Louis.